Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy symbols : Srpt save search
Nicklaus Children's Hospital Now Administering the First FDA-Approved Gene Therapy for Duchenne Muscular Dystrophy
Published: 2023-11-01 (Crawled : 20:00) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: 1.62%
H: 12.24%
C: 11.87%
hospital duchenne therapy
Sarepta Therapeutics Announces Topline Results from EMBARK, a Global Pivotal Study of ELEVIDYS Gene Therapy for Duchenne Muscular Dystrophy
Published: 2023-10-30 (Crawled : 22:00) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: 1.05%
H: 1.86%
C: -0.28%
global topline therapeutics duchenne therapy results study
Orsini Selected by Sarepta Therapeutics to Dispense ELEVIDYS (delandistrogene moxeparvovec-rokl), the First Gene Therapy to Treat Duchenne Muscular Dystrophy
Published: 2023-06-27 (Crawled : 22:00) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.75%
H: 0.43%
C: -1.0%
treat therapeutics duchenne therapy
Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy
Published: 2023-06-22 (Crawled : 22:00) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: 0.06%
H: 2.73%
C: -2.39%
fda approval treat therapeutics duchenne therapy
FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy
Published: 2023-06-22 (Crawled : 18:00) - fda.gov
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -3.2%
H: 0.03%
C: -4.89%
fda treatment duchenne therapy
Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate
Published: 2023-01-05 (Crawled : 14:00) - biospace.com/
CTLT | $55.87 -0.29% 850K
|
Health Technology
|
| O: -1.77%
H: 1.78%
C: 1.18%
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: 0.71%
H: 0.26%
C: -3.38%
partnership candidate commercial agreement duchenne therapy
Sarepta Therapeutics Presents New Data from its Gene Therapy and RNA Platforms at World Muscle Society 2022
Published: 2022-10-07 (Crawled : 13:00) - globenewswire.com
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.45%
H: 0.21%
C: -2.59%
therapeutics therapy
Asia Pacific Cancer Gene Therapy Market Report 2022: Advantages of Cancer Gene Therapy Over Conventional Cancer Medicines, as Well as An Increase in Government Backing Driving Expansion
Published: 2022-08-02 (Crawled : 13:20) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -0.0%
H: 0.6%
C: 0.6%
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
GSK | News | $40.755 -1.18% 660K
|
Health Technology
|
| O: 0.1%
H: 0.58%
C: -1.18%
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.22%
H: 3.68%
C: 2.91%
GILD | $67.03 2.4M
|
Health Technology
|
| O: 0.23%
H: 0.97%
C: -0.33%
expansion report therapy cancer market
Sarepta Therapeutics’ Investigational Gene Therapy SRP-9001 for Duchenne Muscular Dystrophy Demonstrates Significant Functional Improvements Across Multiple Studies
Published: 2022-07-06 (Crawled : 12:20) - globenewswire.com
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -4.28%
H: 6.4%
C: 4.79%
srp-9001 duchenne therapy
Global Gene Therapy Market Research Report 2022-2031 Featuring Major Players - Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc; Audentes Therapeutics; Voyager Therapeutics
Published: 2022-06-20 (Crawled : 12:00) - prnewswire.com
SNY | News | $46.615 -2.25% 730K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 480
|
Health Technology
| Email alert
Add to watchlist
QURE | $4.585 -3.47% 280K
|
Health Technology
| Email alert
Add to watchlist
CLLS | News | $2.53 -3.42% 25K
|
Health Technology
| Email alert
Add to watchlist
SRPT | $117.81 0.59% 220K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 52K
|
Health Technology
| Email alert
Add to watchlist
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
| Email alert
Add to watchlist
BLUE | $0.9227 -4.94% 4.6M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
| Email alert
Add to watchlist
research report novartis therapeutics therapy market
Abeona Therapeutics Appoints Gene Therapy Quality Leader Jon Voss as Vice President, Head of Quality
Published: 2021-10-12 (Crawled : 12:15) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: 2.13%
H: 4.04%
C: 1.97%
GBIO | News | $3.01 -7.67% 35K
|
Health Technology
|
| O: 0.99%
H: 3.26%
C: -0.8%
ABEO | News | $3.195 -6.31% 1.4M
|
Health Technology
|
| O: -0.71%
H: 2.38%
C: -1.74%
gene therapy therapy
Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress
Published: 2021-09-14 (Crawled : 13:00) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.23%
H: 0.82%
C: -1.68%
gene therapy therapy gene therapies
Lysogene Announces First Patient in the United States Dosed with LYS-GM101 Investigational Gene Therapy for the Treatment of GM1 Gangliosidosis
Published: 2021-08-30 (Crawled : 08:00) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.24%
H: 0.97%
C: -2.94%
treatment gene therapy therapy gene therapies
Sarepta Therapeutics Executes Licensing Agreement for Gene Therapy Program from Nationwide Children’s Hospital to Treat Limb-Girdle Muscular Dystrophy Type 2A
Published: 2021-08-04 (Crawled : 13:15) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.43%
H: 2.43%
C: -1.8%
gene therapy therapy children gene therapies license
Global Gene Therapy Market Report 2021: Adeno-associated Virus Vectors - A Leading Platform for Gene Therapy
Published: 2021-07-13 (Crawled : 11:00) - prnewswire.com
QURE | $4.585 -3.47% 280K
|
Health Technology
|
| O: -0.64%
H: 1.28%
C: -1.0%
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.88%
H: 1.98%
C: -1.13%
SGMO | News | $0.4922 -5.51% 700K
|
Health Technology
|
| O: -0.49%
H: 1.63%
C: 0.0%
RGNX | $15.75 -0.94% 120K
|
Health Technology
|
| O: -0.51%
H: 0.95%
C: -1.06%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.05%
H: 0.22%
C: -4.26%
NTLA | $21.1 -2.0% 360K
|
Health Technology
|
| O: -0.48%
H: 1.36%
C: -2.65%
GILD | $67.03 2.4M
|
Health Technology
|
| O: -0.35%
H: 1.01%
C: 0.27%
EDIT | News | $5.375 -1.56% 590K
|
Health Technology
|
| O: -0.15%
H: 1.2%
C: -4.78%
CRSP | News M | $56.02 -0.69% 390K
|
Health Technology
|
| O: -0.47%
H: 0.76%
C: -3.24%
BLUE | $0.9227 -4.94% 4.6M
|
Health Technology
|
| O: -0.7%
H: 0.95%
C: -2.43%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: -2.09%
ALNY | $144.52 -1.06% 140K
|
Health Technology
|
| O: -0.56%
H: 1.51%
C: -0.23%
ADAP | $1.095 -3.95% 540K
|
Health Technology
|
| O: -0.25%
H: 0.25%
C: -1.78%
ABEO | News | $3.195 -6.31% 1.4M
|
Health Technology
|
| O: 2.11%
H: 0.0%
C: -4.83%
gene therapy therapy gene therapies
Lysogene Announces FDA Fast Track Designation for LYS-GM101 Gene Therapy for the Treatment of GM1 Gangliosidosis
Published: 2021-07-08 (Crawled : 20:00) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.43%
H: 2.2%
C: 1.76%
treatment fda fda fast track fast track gene therapy therapy gene therapies fast track designation designation
Global Gene Therapy Market to Reach $2.7 Billion by 2026
Published: 2021-06-29 (Crawled : 14:15) - prnewswire.com
QURE | $4.585 -3.47% 280K
|
Health Technology
|
| O: 0.1%
H: 1.22%
C: -0.26%
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: 0.0%
H: 0.25%
C: -2.43%
SGMO | News | $0.4922 -5.51% 700K
|
Health Technology
|
| O: -0.91%
H: 1.08%
C: -2.66%
RGNX | $15.75 -0.94% 120K
|
Health Technology
|
| O: -0.26%
H: 1.59%
C: -1.13%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.13%
H: 0.1%
C: -8.26%
NTLA | $21.1 -2.0% 360K
|
Health Technology
|
| O: -2.19%
H: 17.95%
C: 16.17%
GILD | $67.03 2.4M
|
Health Technology
|
| O: -0.04%
H: 0.53%
C: 0.38%
EDIT | News | $5.375 -1.56% 590K
|
Health Technology
|
| O: 2.07%
H: 3.99%
C: 2.67%
CRSP | News M | $56.02 -0.69% 390K
|
Health Technology
|
| O: -0.41%
H: 1.48%
C: -0.34%
BLUE | $0.9227 -4.94% 4.6M
|
Health Technology
|
| O: -0.26%
H: 0.64%
C: -3.25%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: -2.44%
ALNY | $144.52 -1.06% 140K
|
Health Technology
|
| O: 0.42%
H: 0.15%
C: -0.62%
ADAP | $1.095 -3.95% 540K
|
Health Technology
|
| O: -0.68%
H: 1.6%
C: 0.23%
ABEO | News | $3.195 -6.31% 1.4M
|
Health Technology
|
| O: 0.0%
H: 0.59%
C: -2.96%
gene therapy therapy gene therapies market
Global Gene Therapy Markets Report 2021-2030: Antigen, Cytokine, Suicide Gene, Viral Vector, Non-Viral Vector, Oncological, Rare Diseases, Cardiovascular, Neurological Disorders, Infectious Diseases
Published: 2021-06-25 (Crawled : 11:00) - prnewswire.com
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
|
| O: 0.16%
H: 0.09%
C: -0.13%
QURE | $4.585 -3.47% 280K
|
Health Technology
|
| O: 0.73%
H: 2.08%
C: 2.01%
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: 0.15%
H: 1.37%
C: 0.75%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
CLLS | News | $2.53 -3.42% 25K
|
Health Technology
|
| O: -0.45%
H: 1.88%
C: 1.3%
BLUE | $0.9227 -4.94% 4.6M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: -4.89%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -1.97%
H: 0.24%
C: -2.72%
disease neurological cardiovascular infectious disease gene therapy therapy cardio gene therapies rare
Lysogene Enters into an Exclusive Worldwide License Agreement with SATT Conectus for a Gene Therapy Candidate for the Treatment of the Fragile X Syndrome
Published: 2021-06-11 (Crawled : 08:00) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.86%
H: 0.91%
C: 0.0%
treatment gene therapy therapy license gene therapies syndros
Lysogene Announces First Patient Dosed with LYS-GM101 Investigational Gene Therapy for the Treatment of GM1 Gangliosidosis
Published: 2021-06-09 (Crawled : 18:00) - biospace.com/
SRPT | $117.81 0.59% 220K
|
Health Technology
|
| O: -0.24%
H: 5.87%
C: 4.1%
treatment gene therapy therapy gene therapies
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.